Literature DB >> 17176037

Solution state characterization of amyloid beta-derived diffusible ligands.

Robert W Hepler1, Karen M Grimm, Deborah D Nahas, Robert Breese, Elizabeth Chen Dodson, Paul Acton, Paul M Keller, Mark Yeager, Hui Wang, Paul Shughrue, Gene Kinney, Joseph G Joyce.   

Abstract

A growing body of evidence suggests that soluble oligomeric forms of the amyloid beta peptide known as amyloid-derived diffusible ligands (ADDLs) are the toxic species responsible for neurodegeneration associated with Alzheimer's disease. Accurate biophysical characterization of ADDL preparations is hampered by the peptide's strong tendency to self-associate and the effect of factors such as ionic strength, temperature, and pH on its behavior. In addition, amyloid peptides are known to interact with common laboratory excipients, specifically detergents, further complicating the results from standard analytical methods such as denaturing polyacrylamide gel electrophoresis. We have studied the solution behavior of various amyloid peptide preparations using analytical ultracentrifugation and size exclusion chromatography coupled with multiangle laser light scattering. Our results indicate that ADDL preparations exist in solution primarily as a binary mixture of a monomeric peptide and high-molecular mass oligomers. We relate our findings to previously described characterizations utilizing atomic force microscopy and electrophoretic methods and demonstrate that low-molecular mass oligomers identified by gel electrophoresis likely represent artifacts induced by the peptide's interaction with detergent, while atomic force microscopy results are likely skewed by differential binding of monomeric and oligomeric peptide species. Finally, we confirm that only the high-molecular mass oligomeric components of an ADDL preparation are capable of binding to subpopulations of primary hippocampal neurons in vitro.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17176037     DOI: 10.1021/bi061850f

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  87 in total

1.  Preparation and characterization of toxic Abeta aggregates for structural and functional studies in Alzheimer's disease research.

Authors:  Asad Jan; Dean M Hartley; Hilal A Lashuel
Journal:  Nat Protoc       Date:  2010-06-03       Impact factor: 13.491

Review 2.  The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes.

Authors:  Iryna Benilova; Eric Karran; Bart De Strooper
Journal:  Nat Neurosci       Date:  2012-01-29       Impact factor: 24.884

3.  Biphasic effects of insulin on islet amyloid polypeptide membrane disruption.

Authors:  Jeffrey R Brender; Edgar L Lee; Kevin Hartman; Pamela T Wong; Ayyalusamy Ramamoorthy; Duncan G Steel; Ari Gafni
Journal:  Biophys J       Date:  2011-02-02       Impact factor: 4.033

4.  Exploring the mechanism of beta-amyloid toxicity attenuation by multivalent sialic acid polymers through the use of mathematical models.

Authors:  Christopher B Cowan; Dhara A Patel; Theresa A Good
Journal:  J Theor Biol       Date:  2009-02-13       Impact factor: 2.691

5.  Selection and structural analysis of de novo proteins from an alpha3beta3 genetic library.

Authors:  Mariejoy Therese Jumawid; Tsuyoshi Takahashi; Toshimasa Yamazaki; Hiroshi Ashigai; Hisakazu Mihara
Journal:  Protein Sci       Date:  2009-02       Impact factor: 6.725

6.  Extracellular calcium modulates actions of orthosteric and allosteric ligands on metabotropic glutamate receptor 1α.

Authors:  Jason Y Jiang; Mulpuri Nagaraju; Rebecca C Meyer; Li Zhang; Donald Hamelberg; Randy A Hall; Edward M Brown; P Jeffrey Conn; Jenny J Yang
Journal:  J Biol Chem       Date:  2013-11-26       Impact factor: 5.157

7.  Modulation of aggregate size- and shape-distributions of the amyloid-beta peptide by a designed beta-sheet breaker.

Authors:  Luitgard Nagel-Steger; Borries Demeler; Wolfgang Meyer-Zaika; Katrin Hochdörffer; Thomas Schrader; Dieter Willbold
Journal:  Eur Biophys J       Date:  2009-02-24       Impact factor: 1.733

8.  The Aggregation Paths and Products of Aβ42 Dimers Are Distinct from Those of the Aβ42 Monomer.

Authors:  Tiernan T O'Malley; William M Witbold; Sara Linse; Dominic M Walsh
Journal:  Biochemistry       Date:  2016-10-26       Impact factor: 3.162

Review 9.  Antibody-Based Drugs and Approaches Against Amyloid-β Species for Alzheimer's Disease Immunotherapy.

Authors:  Jing Liu; Bin Yang; Jun Ke; Wenjia Li; Wen-Chen Suen
Journal:  Drugs Aging       Date:  2016-10       Impact factor: 3.923

Review 10.  Inflammatory mechanisms in neurodegeneration.

Authors:  Michael R Nichols; Marie-Kim St-Pierre; Ann-Christin Wendeln; Nyasha J Makoni; Lisa K Gouwens; Evan C Garrad; Mona Sohrabi; Jonas J Neher; Marie-Eve Tremblay; Colin K Combs
Journal:  J Neurochem       Date:  2019-03-27       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.